Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
VPS41 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCYOX1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CHML - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TTC3P1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC26A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LNPK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
RHNO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC01420 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SNX24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TOR1AIP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RABGAP1L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RRP1B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PHTF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBE2V2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DTD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HP1BP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBIP1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on